DIN 02225166 — SUPREFACT 1 MG
SUPREFACT is a solution of Buserelin marketed by CHEPLAPHARM ARZNEIMITTEL GMBH. The full Buserelin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02225166
- Brand name
- SUPREFACT
- Active ingredient
- Buserelin
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin-releasing hormone (GnRH/LHRH) agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Buserelin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02228955 | SUPREFACT DEPOT 2 MONTHS | 6.3 MG | IMPLANT | CHEPLAPHARM ARZNEIMITTEL GMBH | DORMANT |
| 02240749 | SUPREFACT DEPOT 3 MONTHS | 9.45 MG | IMPLANT | CHEPLAPHARM ARZNEIMITTEL GMBH | DORMANT |